The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy

Urologic Clinics of North America

Volumn 23, Issue 4, 1996, Pages 541-549

  Katz, A E ^a   De Vries, G M ^a   Benson, M C ^a   Buttyan, R E ^a   O'Toole, K ^a   Rubin, M A ^a   Stifelman, M ^a   Olsson, C A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; CANCER DIAGNOSIS; CANCER SURGERY; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0030482721     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70334-7     Document Type: Article

References (40)

1. M. Aihara R.M. Lebovitz T.M. Wheeler Prostate specific antigen and gleason grade: An immunohistochemical study of prostate cancer J Urol 151 1994 1558
2. E.P. Allhoff S.G. Liedke O. Gonnermann Efficient pathway for early detection of prostate cancer concluded from a 5-year prospective study World J Urol 11 1993 201
3. C.H. Blood B.R. Zetter Tumor interactions with the vasculature: Angiogenesis and tumor metastasis Biochem Biophys Acta 1032 1990 89
4. S.A. Burchill M.F. Bradbury K. Pittman Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction Br J Cancer 71 1995 278
5. F.M. Chybowski J.J. Keller E.J. Bergstralh Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: Prostate specific antigen is superior to all other clinical parameters J Urol 145 1991 313
6. Y.H. Datta P.T. Adams W.R. Drobyski Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction J Clin Oncol 12 1994 475
7. J.I. Epstein G. Pizov P.C. Walsh Correlation of pathologic findings with progression after radical retropubic prostatectomy Cancer 71 1993 3582
8. P.H. Gann C.H. Hennekens M.J. Stampfer A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer JAMA 273 1995 289
9. F.C. Hamdy J. Lawry J. Anderson Circulating prostate specific antigen-positive cells correlate with metastatic prostate cancer J Urol 69 1992 392
10. J.S. Horoszewicz S.S. Leong E. Kawinski LnCaP model of human prostatic carcinoma Cancer Res 43 1983 1809
11. J. Iwakiri K. Granbois N. Wehner An analysis of urinary prostate specific antigen before and after radical prostatectomy: Evidence for secretion of prostate specific antigen by the periurethral glands J Urol 149 1993 783
12. J.N. Kabalin J.E. McNeal I.M. Johnstone Serum prostate-specific antigen and the biologic progression of prostate cancer Urology 46 1995 65
13. E.L. Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457
14. A.E. Katz de Vries G.M. M.D. Begg Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer Cancer 75 1995 1642
15. A.E. Katz C.A. Olsson A.J. Raffo Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay Urology 43 1994 765
16. H.G. Klobeck G. Combriato P. Schulz Genomic sequence of human prostate specific antigen (PSA) Nucleic Acids Res 17 1989 3981
17. F. Lee P.J. Littrup The role of digital rectal examination, transrectal ultrasound, and prostate specific antigen for the detection of confined and clinically relevant prostate cancer J Cell Biochem 16H suppl 1992 69
18. Z. Levran J.A. Gonzalez A.C. Diokno Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 75 1995 778
19. H. Lilja Structure, function, and regulation of the enzyme activity of prostate-specific antigen World J Urol 11 1993 188
20. A. Lundwall H. Lilja Molecular cloning of human prostate specific antigen cDNA FEBS Lett 214 1987 317
21. G.L. Lu-Yao D. Mclerran J. Watson An assessment of radical prostatectomy: Time trends, geographic variation and outcomes JAMA 269 1993 2633
22. M. Monne C.M. Croce H. Yu Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors Cancer Res 54 1994 6344
23. M. Mori K. Mimori H. Inoue Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction Cancer Res 55 1995 3417
24. E. Mukamel J. Hanna deKernion J.B. Pitfalls in preoperative staging in prostate cancer Urology 30 1987 318
25. S. Noguchi T. Aihara S. Nakamori The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction Cancer 74 1994 1595
26. M. Ohori T.M. Wheeler P.T. Scardino The New American Joint Committee on Cancer and International Union Cancer TNM classification of prostate cancer Cancer 74 1994 104
27. CA Olsson, de Vries GM, MC Benson, et al. Pre-operative RT-PCR for PSA predicts treatment failure following radical prostatectomy. J Urol, in press
28. A.W. Partin J. Yoo H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110
29. A.W. Partin C.R. Pound J.Q. Clemens Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years Urol Clin North Am 20 1993 713
30. V. Ravery L.A. Boccon-Gibod A. Meuleman Predictive value of pathological features for progression after radical prostatectomy Eur Urol 26 1994 197
31. J.P. Richie L.R. Kavoussi G.T. Ho Prostate cancer screening: Role of the digital rectal examination and prostate-specific antigen Ann Surg Oncol 1 1994 117
32. M.D. Rifkin E.A. Zerhouni C.A. Gatsonis Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial N Engl J Med 323 1990 621
33. J.O. Salo L. Kivisarri S. Rannikko Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic carcinoma before radical retropubic prostatectomy J Urol 137 1987 435
34. R. Scaletscky M.O. Koch C.W. Eckstein Tumor volume and stage in carcinoma of the prostate detected by elevations in prostate specific antigen J Urol 152 1994 129
35. M.R. Smith S. Biggar M. Hussain Prostate-specific antigen messenger RNA is expressed in non-prostate cells: Implications for detection of micrometastases Cancer Res 55 1995 2640
36. J.G. Trapasso deKernion J.B. R.B. Smith The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821
37. M.C. Wang L.A. Valenzuela G.P. Murphy Purification of a human prostate specific antigen Invest Urol 17 1979 159
38. H. Yu E.P. Diamandis M. Monne Oral contraceptive-induced expression of prostate-specific antigen in the female breast J Biol Chem 270 1995 6615
39. H. Yu M. Giai E.P. Diamandis Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer Cancer Res 55 1995 2104
40. H. Zincke J.E. Oesterling M.L. Blute Long term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer J Urol 152 1994 1850